Abbott Laboratories
Price Action
Technical Summary
DOWNTRENDAbbott Laboratories is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 14), showing significant lag compared to the market leaders. However, RSI is deeply oversold at 24, suggesting potential for a mean-reversion bounce.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $94.09 | -8.34% | BELOW |
| 50 SMA | $102.44 | -15.81% | BELOW |
| 100 SMA | $110.39 | -21.87% | BELOW |
| 150 SMA | $116.24 | -25.80% | BELOW |
| 200 SMA | $120.01 | -28.14% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ABT in an uptrend right now?
ABT has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is ABT overbought or oversold?
ABT's RSI (14) is 24. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.
Is ABT outperforming the market?
ABT has a Relative Strength (RS) Rating of 14 out of 99. ABT is currently lagging the broader market.
Where is ABT in its 52-week range?
ABT is trading at $86.25, which is 62% of its 52-week high ($139.06) and 0% above its 52-week low ($86.15).
How volatile is ABT?
ABT has a Beta of 0.25 and 52-week volatility of 23%. It's less volatile than the S&P 500 - generally more stable.